Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with ... Monthly Prescribing Reference SAN DIEGO, CA—Standard-dose rituximab plus multiple courses of pulse dexamethasone was shown to be active with manageable toxicity in patients with immune thrombocytopenia (ITP), according to results of a retrospective analysis presented during the ... |
